These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6787698)

  • 1. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1976-1979).
    Triplett DA; Kocoshis TA; Harms CS
    Scand J Haematol Suppl; 1980; 37():116-29. PubMed ID: 6787698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cap survey results for factor VIII assays (1977-1978).
    Kocoshis TA; Triplett DA
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):346-51. PubMed ID: 474513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI assay results in the CAP survey (1981).
    Pearson RW; Triplett DA
    Am J Clin Pathol; 1982 Oct; 78(4 Suppl):615-20. PubMed ID: 7137102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of assays of factor VIII and factor IX.
    Barrowcliffe TW
    Ric Clin Lab; 1990; 20(2):155-65. PubMed ID: 2115197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators.
    Dodt J; Hubbard AR; Wicks SJ; Gray E; Neugebauer B; Charton E; Silvester G
    Haemophilia; 2015 Jul; 21(4):543-9. PubMed ID: 25623631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proficiency testing of factor VIII:C activity assays at the Canadian Red Cross Society National Reference Laboratory.
    Wasi S; Murray SA; Gill P
    Vox Sang; 1994; 67(1):1-7. PubMed ID: 7975443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory performance of haemophilia centres in developing countries: 3 years' experience of the World Federation of Hemophilia External Quality Assessment Scheme.
    Jennings I; Kitchen S; Woods TA; Preston FE
    Haemophilia; 1998 Sep; 4(5):739-46. PubMed ID: 9873880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Stage Factor VIII Assays.
    Duncan E; Rodgers S
    Methods Mol Biol; 2017; 1646():247-263. PubMed ID: 28804834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of factor VIII and factor IX.
    Baglini RL
    Am J Med Technol; 1983 Dec; 49(12):857-62. PubMed ID: 6422755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
    Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
    Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current laboratory practices in the diagnosis and management of haemophilia: a global assessment.
    Kitchen S; Signer-Romero K; Key NS
    Haemophilia; 2015 Jul; 21(4):550-7. PubMed ID: 25688866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of composition of reagents for activated partial thromboplastin time on their sensitivity during analysis of blood coagulation factors].
    Berkovskiĭ AL; Vasil'ev SA; Sergeeva EV; Kozlov AA
    Klin Lab Diagn; 2000 Apr; (4):34-8. PubMed ID: 10878941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.